Bosmolisib

BR101801 · Boryung Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bosmolisib, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Bosmolisib (BR101801) in Participants With R/R PTCL. [Phase 2]